Strategic Investment Advisors Laboratory Corp Of America Holdings Transaction History

Strategic Investment Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$209.01 - $232.56 $3,971 - $4,418	19 Added 1.57%	1,232 $269,000
Q4 2023 Jan 10, 2024	SELL	$197.69 - $227.29 $1,976 - $2,272	-10 Reduced 0.82%	1,213 $275,000
Q3 2023 Oct 24, 2023	BUY	$201.05 - $221.7 $245,884 - $271,139	1,223 New	1,223 $245,000
Q1 2023 Apr 27, 2023	BUY	$213.32 - $257.83 $261,743 - $316,357	1,227 Added 21.1%	7,041 $1.62 Million
Q4 2022 Jan 19, 2023	BUY	$203.72 - $248.97 $161,753 - $197,682	794 Added 15.82%	5,814 $0
Q3 2022 Oct 27, 2022	BUY	$204.81 - $262.19 $10,240 - $13,109	50 Added 1.01%	5,020 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $129,813 - $168,667	607 Added 13.91%	4,970 $1.17 Million
Q1 2022 Apr 28, 2022	BUY	$259.82 - $298.18 $130,169 - $149,388	501 Added 12.97%	4,363 $1.15 Million
Q4 2021 Jan 26, 2022	BUY	$271.6 - $314.21 $30,147 - $34,877	111 Added 2.96%	3,862 $1.21 Million
Q3 2021 Oct 19, 2021	BUY	$274.82 - $308.34 $1.03 Million - $1.16 Million	3,751 New	3,751 $1.06 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.